Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vbi Vaccines Inc CS (NQ: VBIV ) 0.6510 -0.0090 (-1.36%) Streaming Delayed Price Updated: 9:52 AM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 18,051 Open 0.6800 Bid (Size) 0.6400 (8) Ask (Size) 0.6500 (447) Prev. Close 0.6600 Today's Range 0.6510 - 0.6801 52wk Range 0.4500 - 1.533 Shares Outstanding 28,682,275 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News VBI Vaccines Announces Results of Annual General Meeting June 25, 2024 From VBI Vaccines Inc. Via Business Wire VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients May 29, 2024 From VBI Vaccines Inc. Via Business Wire Performance YTD +5.66% +5.66% 1 Month +9.34% +9.34% 3 Month +3.38% +3.38% 6 Month +3.33% +3.33% 1 Year -56.60% -56.60% More News Read More VBI Vaccines Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients May 22, 2024 From VBI Vaccines Inc. Via Business Wire VBIV Stock Earnings: VBI Vaccines Misses EPS, Misses Revenue for Q1 2024 May 15, 2024 Via InvestorPlace VBI Vaccines Reports First Quarter 2024 Financial Results May 15, 2024 From VBI Vaccines Inc. Via Business Wire VBIV Stock Earnings: VBI Vaccines Beats EPS, Misses Revenue for Q4 2023 April 16, 2024 Via InvestorPlace VBI Vaccines Reports Full Year 2023 Financial Results April 16, 2024 From VBI Vaccines Inc. Via Business Wire VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules April 11, 2024 From VBI Vaccines Inc. Via Business Wire Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 11, 2024 Via Benzinga VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules April 09, 2024 From VBI Vaccines Inc. Via Business Wire Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket April 09, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday April 05, 2024 Via InvestorPlace VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma April 03, 2024 From VBI Vaccines Inc. Via Business Wire VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform April 02, 2024 From VBI Vaccines Inc. Via Business Wire Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session February 14, 2024 Via Benzinga Why Robinhood Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket February 14, 2024 Via Benzinga VBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii Biosciences February 14, 2024 From VBI Vaccines Inc. Via Business Wire Why Faraday Future Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket November 24, 2023 Via Benzinga VBI Vaccines Presents Additional Biomarker Data from Phase 1/2a Study of VBI-1901 in Recurrent GBM at the 2023 Society for Neuro-Oncology (SNO) Annual Meeting November 20, 2023 From VBI Vaccines Inc. Via Business Wire VBI Vaccines Reports Third Quarter 2023 Financial Results November 14, 2023 From VBI Vaccines Inc. Via Business Wire VBI Vaccines Expands Proprietary Technology Platforms With Development of a Novel mRNA-Launched eVLP Vaccine Program October 26, 2023 From VBI Vaccines Inc. Via Business Wire Stocks That Hit 52-Week Lows On Thursday October 05, 2023 Via Benzinga Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session September 27, 2023 Via Benzinga VBI Vaccines’ Pan-Coronavirus Vaccine Candidate, VBI-2901, Induced Broad and Durable Protective Titers Against Variants of Concern September 27, 2023 From VBI Vaccines Inc. Via Business Wire Stocks That Hit 52-Week Lows On Thursday September 21, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
